Definition

Vector-borne diseases are illnesses transmitted by vectors—living organisms (typically arthropods like mosquitoes, ticks, or fleas) that carry pathogens from one host to another. Vectors themselves do not cause disease but are essential for pathogen transmission.

Scientific Importance

  • Epidemiology: Vector-borne diseases are central to understanding infectious disease dynamics, especially in relation to climate, ecology, and genetics.
  • Pathogen Evolution: Vectors influence pathogen adaptation and virulence, affecting disease emergence and transmission.
  • Interdisciplinary Research: Studies integrate entomology, microbiology, immunology, ecology, and public health.

Major Vector-Borne Diseases

Disease Vector Pathogen Type Key Regions
Malaria Mosquito Protozoa Sub-Saharan Africa, S. Asia
Dengue Mosquito Virus Tropics, Subtropics
Lyme Disease Tick Bacteria N. America, Europe
Chikungunya Mosquito Virus Africa, Asia, Americas
Zika Virus Mosquito Virus Americas, SE Asia
Trypanosomiasis Tsetse Fly Protozoa Africa
Plague Flea Bacteria Global (historically)

Societal Impact

  • Global Health Burden: Over 1 billion cases and 1 million deaths annually (WHO).
  • Economic Costs: Healthcare expenses, lost productivity, and vector control programs.
  • Social Disruption: School absenteeism, migration, and stigma.
  • Vulnerable Populations: Children, elderly, and immunocompromised individuals are disproportionately affected.
  • Urbanization & Climate Change: Expansion of vector habitats due to changing temperatures and human activities.

Recent Breakthroughs

  • Gene-Drive Mosquitoes: CRISPR-based gene editing to reduce mosquito populations or render them incapable of transmitting diseases (Kyrou et al., Nature Biotechnology, 2022).
  • mRNA Vaccines: New platforms for rapid vaccine development against vector-borne viruses (e.g., Zika, Chikungunya).
  • Remote Sensing & AI: Satellite data and machine learning for vector surveillance and outbreak prediction.
  • Integrated Vector Management (IVM): Combining biological, chemical, and environmental strategies for sustainable control.
  • Discovery of New Vectors: Identification of Aedes vittatus as a competent vector for multiple arboviruses (Moutailler et al., Emerging Infectious Diseases, 2021).

Citation:
Kyrou K, Hammond AM, Galizi R, et al. “A CRISPR–Cas9 gene drive targeting doublesex causes complete population suppression in caged Anopheles gambiae mosquitoes.” Nature Biotechnology, 2022.

Practical Experiment: Mosquito Oviposition Preference

Objective:
Investigate the effect of water quality on mosquito egg-laying behavior.

Materials:

  • 3 containers with different water types (clean, polluted, brackish)
  • Mosquitoes (lab strain)
  • Netting, gloves, pipettes
  • Data sheet

Method:

  1. Place equal numbers of female mosquitoes in cages with the three water containers.
  2. Allow 48 hours for oviposition.
  3. Count and record the number of eggs in each container.
  4. Analyze data for preference patterns.

Expected Outcome:
Mosquitoes may prefer certain water types, informing vector control strategies.

Ethical Issues

  • Gene Editing: Release of genetically modified vectors raises concerns about ecological impact, unintended consequences, and biodiversity.
  • Informed Consent: Community engagement and consent are crucial for field trials.
  • Equity: Access to interventions (e.g., vaccines, bed nets) must be fair and not exacerbate social inequalities.
  • Privacy: Use of surveillance technology for outbreak tracking must respect individual privacy.
  • Animal Welfare: Ethical treatment of animals in vector research and experimentation.

FAQ

Q: Why are vector-borne diseases increasing globally?
A: Factors include climate change, urbanization, global travel, and insecticide resistance.

Q: Can vector-borne diseases be eradicated?
A: Complete eradication is challenging due to complex ecology, but local elimination is possible with integrated strategies.

Q: How does plastic pollution relate to vectors?
A: Plastic waste in water bodies creates breeding sites for mosquitoes, increasing disease risk in affected regions.

Q: What are the most promising interventions?
A: Gene-drive technology, improved vaccines, and integrated vector management show strong potential.

Q: Are vector-borne diseases only a problem in tropical regions?
A: No; climate change is expanding their range into temperate zones.

Q: How is research advancing in this field?
A: Advances in genomics, remote sensing, and AI are transforming surveillance and control.

Additional Notes

  • Plastic Pollution Link: Recent studies (e.g., Science Advances, 2021) confirm plastic debris in oceans and rivers provides habitats for vector larvae, compounding public health risks.
  • One Health Approach: Recognizes the interconnectedness of human, animal, and environmental health in managing vector-borne diseases.
  • Antimicrobial Resistance: Vector-borne pathogens are increasingly resistant to drugs, complicating treatment.

References

  1. Kyrou K, Hammond AM, Galizi R, et al. “A CRISPR–Cas9 gene drive targeting doublesex causes complete population suppression in caged Anopheles gambiae mosquitoes.” Nature Biotechnology, 2022.
  2. Moutailler S, et al. “Emerging threats from new vector species.” Emerging Infectious Diseases, 2021.
  3. “Plastic pollution in the world’s oceans: More than meets the eye.” Science Advances, 2021.
  4. World Health Organization. “Vector-borne diseases.” Fact Sheet, 2023.

End of Revision Sheet